Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Clinical trial NCT07441395 · RECRUITING
Trial details
- NCT number
- NCT07441395
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.